Select Publications

August 7, 2020

Publications

References

Aisen, P. S, R. C. Petersen, M. C. Donohue, A. Gamst, R. Raman, R. G. Thomas, S. Walter, J. Q. Trojanowski, L. M. Shaw, L. A. Beckett, and others (2010). “Clinical Core of the Alzheimer’s Disease Neuroimaging Initiative: progress and plans”. In: Alzheimer’s & Dementia 6.3, pp. 239-246.

Amariglio, R. E, M. C. Donohue, G. A. Marshall, D. M. Rentz, D. P. Salmon, S. H. Ferris, S. Karantzoulis, P. S. Aisen, and R. A. Sperling (2015). “Tracking early decline in cognitive function in older individuals at risk for Alzheimer disease dementia: the Alzheimer’s Disease Cooperative Study Cognitive Function Instrument”. In: JAMA neurology 72.4, pp. 446-454.

Donohue, M. C, A. Gamst, R. Thomas, R. Xu, L. Beckett, R. C. Petersen, M. Weiner, P. Aisen, A. D. N. Initiative, and others (2011). “The relative efficiency of time-to-threshold and rate of change in longitudinal data”. In: Contemporary clinical trials 32.5, pp. 685-693.

Donohue, M. C, R. Overholser, R. Xu, and F. Vaida (2011). “Conditional Akaike information under generalized linear and proportional hazards mixed models”. In: Biometrika 98.3, pp. 685-700.

Donohue, M. C, R. A. Sperling, R. Petersen, C. Sun, M. W. Weiner, and P. S. Aisen (2017). “Association between elevated brain amyloid and subsequent cognitive decline among cognitively normal persons”. In: JAMA 317.22, pp. 2305-2316.

Donohue, M. C, R. A. Sperling, D. P. Salmon, D. M. Rentz, R. Raman, R. G. Thomas, M. Weiner, and P. S. Aisen (2014a). “The preclinical Alzheimer cognitive composite: measuring amyloid-related decline”. In: JAMA neurology 71.8, pp. 961-970.

Donohue, M., P. Aisen, J. Dartigues, H. Jacqmin-Gadda, A. Gamst, and M. Le Goff (2012). “Validating Alzheimer’s pathological cascade by merging ADNI with PAQUID”. In: Alzheimer’s and Dementia. Vol. 8. 4. , p. 611.

Iddi, S, D. Li, P. S. Aisen, M. S. Rafii, I. Litvan, W. K. Thompson, and M. C. Donohue (2018). “Estimating the evolution of disease in the Parkinson’s Progression Markers Initiative”. In: Neurodegenerative Diseases 18.4, pp. 173-190.

Iddi, S, D. Li, P. S. Aisen, M. S. Rafii, W. K. Thompson, M. C. Donohue, A. D. N. Initiative, and others (2019). “Predicting the course of Alzheimer’s progression”. In: Brain informatics 6.1, p. 6.

Li, D, S. Iddi, P. S. Aisen, W. K. Thompson, M. C. Donohue, A. D. N. Initiative, and others (2019). “The relative efficiency of time-to-progression and continuous measures of cognition in presymptomatic Alzheimer’s disease”. In: Alzheimer’s & Dementia: Translational Research & Clinical Interventions 5, pp. 308-318.

Li, D, S. Iddi, W. K. Thompson, M. C. Donohue, and A. D. N. Initiative (2019). “Bayesian latent time joint mixed effect models for multicohort longitudinal data”. In: Statistical methods in medical research 28.3, pp. 835-845.

Petersen, R. C, P. Aisen, L. A. Beckett, M. Donohue, A. Gamst, D. J. Harvey, C. Jack, W. Jagust, L. Shaw, A. Toga, and others (2010). “Alzheimer’s disease neuroimaging initiative (ADNI): clinical characterization”. In: Neurology 74.3, pp. 201-209.

Sperling, R, M. Donohue, and P. Aisen (2012). “The A4 trial: anti-amyloid treatment of asymptomatic Alzheimer’s disease”. In: Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association 8.4, pp. P425-P426.